SENSITIVITY OF DRUG-RESISTANT B-CELL LINES FROM AIDS-RELATED NON-HODGKINS-LYMPHOMA TO NEWLY SYNTHESIZED PODOPHYLLOTOXIN DERIVATIVES AND AZA-ALKYLLYSOPHOSPHOLIPIDS - ENHANCED SENSITIZATION BY PRETREATMENT WITH INTERFERON-GAMMA
A. Demidem et al., SENSITIVITY OF DRUG-RESISTANT B-CELL LINES FROM AIDS-RELATED NON-HODGKINS-LYMPHOMA TO NEWLY SYNTHESIZED PODOPHYLLOTOXIN DERIVATIVES AND AZA-ALKYLLYSOPHOSPHOLIPIDS - ENHANCED SENSITIZATION BY PRETREATMENT WITH INTERFERON-GAMMA, International journal of oncology, 4(6), 1994, pp. 1203-1209
Non-Hodgkin's lymphoma B cells (NHL-B) often become refractory to conv
entional chemotherapeutic drugs. The present study investigated the se
nsitivity of three AIDS-derived NHL-B cell lines to newly synthesized
azaalkyllysophospholipids (AALP) and podophyllotoxin derivatives. All
three cell lines were sensitive to 5 AALP derivatives and toxicity was
detectable at 24 h of culture and was increased at 48 and 72 h of inc
ubation. Toxicity was concentration-dependent and die extent of cytoto
xicity varied slightly from one cell line to another. These cell lines
were less sensitive to the podophyllotoxin derivatives VP-16, BDPTN a
nd BEPT than to die AALP. This was shown by the extent of cytotoxicity
calculated on a molar basis and by the delayed kinetics of lysis. Pre
treatment of the tumor cells with IFN-gamma stimulated cell proliferat
ion. IFN-gamma treated tumor cells were also tested for their sensitiv
ity to the various cytotoxic agents. In all cases, the sensitivity of
the IFN-gamma pretreated cell lines to the podophyllotoxin derivatives
and AALP was significantly enhanced. These findings demonstrate that
drug resistant NHL-B cells are sensitive to a new family of AALP and p
odophyllotoxin derivatives. Further, the sensitivity of the tumor cell
s was enhanced by treatment with IFN-gamma. The potential clinical use
of these new cytotoxic agents to overcome resistance of AIDS-related
cell lymphomas is discussed.